Type 3 iodothyronine deiodinase (D3) catalyzes the conversion of T4 and T3 to inactive metabolites. It is highly expressed in placenta and thus can regulate circulating fetal thyroid hormone concentrations throughout gestation. We have cloned and expressed a 2.1-kb human placental D3 cDNA which encodes a 32-kD protein with a Km of 1.2 nM for 5 deiodination of T3 and 340 nM for 5' deiodination of reverse T3. The reaction requires DTT and is not inhibited by 6n-propylthiouracil. We quantitated transiently expressed D3 by specifically labeling the protein with bromoacetyl [12"'I T3. The KatIK. ratio for 5 deiodination of T3 was over 1,000-fold that for 5' deiodination of reverse T3. Human D3 is a selenoenzyme as evidenced by (a) the presence of an in frame UGA codon at position 144, (b) the synthesis of a 32-kD 75Se-labeled protein in D3 cDNA transfected cells, and (c) the presence of a selenocysteine insertion sequence element in the 3' untranslated region of the mRNA which is required for its expression. The D3 selenocysteine insertion sequence element is more potent than that in the type 1 deiodinase or glutathione peroxidase gene, suggesting a high priority for selenocysteine incorporation into this enzyme. The conservation of this enzyme from Xenopus laevis tadpoles to humans implies an essential role for regulation of thyroid hormone inactivation during embryological development. (J. Clin. Invest. 1995. 96:2421-2430
Introduction
Thyroid hormone is critical to the normal development of the human central nervous system (CNS) .' Despite the presence thyronine deiodinase; GH, growth hormone; GTG, gold thioglucose; h, human; HEK, human embryonic kidney; nt, nucleotide; PE, phosphate/ EDTA buffer; PTU, 6n-propylthiouracil; SECIS, selenocysteine insertion sequence; SEl D, selenophosphate synthetase, TK, thymidine kinase; ut, untranslated.
of thyroxine (T4) and thyroid follicles in the fetal thyroid by [10] [11] [12] wk of gestation as well as the potential availability of maternal thyroid hormone, the free concentration of the active thyroid hormone, 3,5,3 '-triiodothyronine (T3), is less than half that of maternal levels up to the time of delivery (1-3). The physiological rationale for this circumstance is not well understood but is thought to permit the precise timing and regulation of T3 delivery to the CNS by coordination of the expression and action of the type 25 '-iodothyronine deiodinase (for review see reference 4). This enzyme uses tissue T4 as a substrate to produce T3 locally and is the primary source of T3 for this organ (5) . It is also possible that normal circulating T3 concentrations could have deleterious effects on immature tissues or could enhance the metabolic requirements of the fetus.
There are two principal mechanisms by which the circulating fetal T3 concentration is maintained at low levels. One is that the type 1 iodothyronine deiodinase (Dl) in fetal liver is expressed at low levels relative to those in adult life (for review see references 6 and 7) . This reduces the extrathyroidal T3 supply from this source. The second important factor in maintaining low serum T3 concentrations is the expression of high levels of the type 3 deiodinase (D3) in placenta of all species so far examined (for review see references 4, [6] [7] [8] . This deiodinase catalyzes the inner ring deiodination of T3 and T4 inactivating circulating iodothyronines as well as minimizing transplacental passage of maternal hormone. D3 activity is also expressed in brain, especially in the rat fetus, in fetal rat skin and intestine, as well as in embryonic chick liver (6, 7) . In humans, placental D3 is sufficiently potent that instillation of 700 ,ug of T4 into amniotic fluid at term causes insignificant increases in the neonatal serum T3 concentration assessed 24 h later (9) .
The cDNAs encoding the DI enzymes of several species have been cloned, and all have been shown to contain the rare amino acid selenocysteine (10) (11) (12) . The requirement for selenium in the active center of this enzyme for maximum activity can explain the increased ratio of T4 to T3 in the circulation and the significant decrease in DI activity in the liver and kidney of rats made selenium deficient (13, 14) . However, selenium deficiency has no effect on placental D3 activity nor can a selenium-labeled protein be identified in rat placental microsomes ( 15, 16) . This has led to the conclusion that this enzyme does not contain selenocysteine. On the other hand, St. Germain et al. recently identified a T3-responsive cDNA found in Xenopus laevis tadpoles as one encoding a D3 enzyme (XD3) (17) . The XD3 protein is 50% identical to rat DI and contains an in frame UGA codon and selenocysteine insertion sequence (SECIS) element in the 3'-untranslated region of the mRNA (17) . A SECIS element is a stem loop sequence which is required for suppression of the stop codon function of UGA and the insertion of selenocysteine (18 2 (AG)TG(AGCT)GC(CT)TC(CT) TC(AGT)AT(AG)TA(AGT)-AT (AGT)AT. We used these oligos in a reverse transcriptase-PCR reaction with 2 /sg of human placental poly(A) + RNA as template. Total RNA was prepared from human placenta using the guanidium method ( 19) . Poly(A) + RNA was isolated by chromatography on oligo-(dt) cellulose type 7 (Pharmacia LKB Biotechnology, Inc., Piscataway, NJ). We amplified a fragment 120 bp long using the above oligos and subcloned this into pBluescript (pBS, Stratagene Inc. Preparation of hD3, XD3, and SelD vectors for eukaryotic expression. To confirm that this clone encoded the type 3 deiodinase, a 1.9-kb insert containing 35 bp of 5' untranslated (ut) region (186-2066) (Fig 1) was excised from pBluescript and inserted into the XhoI/NotI sites of CDM-8, a mammalian expression vector (20 (27) . Data were quantified and values for Vma, and Km estimated using double reciprocal plots as previously described (17) . Data were subjected to one-way ANOVA, and statistical differences among groups were determined using Duncan's multiple range test (28) .
Bromoacetyl (BrAc) [125f IT3 affinity labeling and enzyme quantitation. BrAc [1251] T3 was synthesized from bromoacetylchloride and T3 as described previously (29) . The product was purified on LH-20 Sephadex by elution with ethanol and purity verified by thin layer chromatography in ethyl acetate/glacial acetic acid (9:1), and the concentration of the product was determined from the specific activity of the T3 used in the starting material as described previously. In some experiments, labeled BrAcT3 was diluted with 0.01-3.0 pmol of unlabeled BrAcT3 synthesized in the same manner. In each reaction 0.05 mCi (- 10 (30) . 3 d before transfection, these cells were plated onto 60-mm dishes in DME containing 10% FCS. 1 d before transfection the media was changed to DME containing 1% FCS supplemented with 100 pM T3, 10 mg/ml transferrin, 20 Ag/ml insulin, and 50 nM hydrocortisone to decrease the medium selenium concentrations. The day after transfection, the cells were shocked with 10% DMSO and fresh media containing 5 nM unlabeled Na2SeO3 plus 6 (Fig. 1) . Since the first 5' 118 nt of 700D3 was found to be 100% identical to the published sequence of the human lymphocyte antigen CD38 (Fig. 1 Fig. 2) and is followed by a short poly A tail. The deduced amino acid sequence predicts a protein of 278 residues, with a molecular mass of 31.5 kD assuming the TGA codon at position 650-652 encodes selenocysteine. HD3 is highly homologous to the XD3 enzyme, 66% identity at the nucleotide level and 58% identity (73% similarity) to the XD3 deduced amino acid sequence. The human enzyme contains a 12-amino acid insert in the amino-terminal region and is seven residues longer than XD3 (Fig. 3 A) . There is also a potential N-glycosylation site (NXS) in the predicted sequence at residues 222-224 which is conserved in XD3. An hydropathy analysis (Fig. 3 B) revealed a hydrophobic amino-terminal portion consistent with a transmembrane domain.
Northern blotting. A 32P-labeled hD3 full-length cDNA hybridizes to a single mRNA species of 2.1-2.2 kb in human placenta (Fig. 4 A) (Fig. 6) . The estimated order of potency of these compounds to block BrAcT3 labeling mirrors that expected from the substrate specificities of the human or rat placental enzyme, with T3> T4>> rT3 (Fig. 6 A) (6) (7) (8) . Also 3,5-diiodothyronine (3,5,-T2) and 3,3' T2 (Fig. 6 B) (Table I ). The enzyme requires DTT as cofactor in the deiodination reaction, with maximal SD activity observed at 10 mM DTT (Fig. 7 B) . GTG is a competitive inhibitor of T3 5 deiodination, with an apparent K, of 5.2 HtM (Fig. 7 A) . The enzyme is insensitive to 6n-propylthiouracil (PTU) inhibition, with no effect observed up to concentrations of 1 mM at varying DTT levels (Fig. 7 B) . Shown in Table I are the values for [E], the picomoles of specifically bound BrAcT3/mg HEK-293 cell sonicate protein in the preparation used for kinetic analyses. Using these results, (Table I) .
Type 3 deiodinase also catalyzes 5' deiodination of reverse T3, although with much lower efficiency. For reverse T3 to 3,3 ' T2 conversion, the Km was 0.33 1iM and the Vm,, is 0.24 U (Table. I ). The Kcat for 5' deiodination of rT3 is 1.4 molecules min-', about 10-fold lower than that for the 5 deiodination of T3 with the KcatlKm ratio of 3.8 min-' mM-1 markedly lower than that for 5 deiodination (Table I) . GTG also inhibits 5' deiodination of reverse T3, with an apparent K, of 0.9 MM (Fig.   7 C) . This reaction was also insensitive to PTU inhibition at concentrations up to 1 mM.
Labeling of hD3, XD3, and rDI with 75Se. To establish that the transiently expressed hD3 incorporates selenium, HtTA cells were transfected with the hD3 cDNA and incubated with Na2[75Se]03 for 18 h. The hD3 cDNA encodes an 32-kD 75Se-labeled protein and its 75Se-labeling is enhanced 10-fold by cotransfection with the human selenophosphate synthetase cDNA, SelD (Fig. 8) . In the same experiment, we also could identify the 75Se-labeled rat DI protein, which appears as a radiolabeled 29-kD band in the rDl cDNA transfected cells (Fig. 8) . With a threefold longer exposure time, a -30-kD band could be seen in XD3 cDNA transfected cells indicating that the rate of synthesis or the efficiency of selenocysteine incorporation into the Xenopus enzyme is much lower than that of hD3.
The hD3 mRNA contains a SECIS element. We have previously shown that eukaryotic selenoprotein mRNAs contain SECIS elements in the 3' ut region which are necessary and sufficient for selenocysteine incorporation at UGA codons (18, 32) . Transfection of a cDNA in which the 3' ut region (3' to nt 1118) is deleted did not produce a functional deiodinase indicating the presence of SECIS activity in the 3' ut of hD3 (Fig. 9) . To confirm this and to compare the potency of the hD3 SECIS element with that of the rat DI mRNA, we inserted the hD3 3' ut region (nt 1118-1720) downstream of the rat Dl cDNA coding region. In the absence of an intact SECIS element, this construct does not express a functional DI (Fig.  9) . The deiodinase activity of the DI-hD3(SECIS) construct was 4.5-fold higher than that of the wild-type Dl cDNA, similar to that of the previously characterized DI-selenoprotein P (SECIS) construct (32) . These results indicate there is a highly potent SECIS element in 3' ut region of the hD3 mRNA.
Analysis by a folding program was used to determine if the inserted SECIS sequence would be predicted to form a stemloop structure, similar to that of the DI SECIS element. Five potential stem loops were predicted by this program, but the segment between nt 1480 and 1720 (Fig. 10 A) , had the highest negative free energy (-44.5 kcal). To localize the SECIS activity more precisely we prepared a construct in which these sequences were inserted 3 ' to the DI coding region. This sequence is able to drive DI expression with an efficiency about 50% of the parent D1-D3(SECIS) construct (Fig. 9) . Thus, while this mRNA segment still has twice the activity of the DI element, additional sequences 5' to 1480 are necessary for the full hD3 SECIS potency.
Discussion
Human D3 is closely related to Xenopus D3 and human Dl. Type 3 deiodinase catalyzes the conversion of T4 to reverse T3 and T3 to 3,3 '-T2, both metabolically inactive products. The D3 enzyme thus shares with Dl the capacity to inactivate thyroid hormone though D3 does not accept sulfated iodothyronines which are highly preferred for inner-ring deiodination by Dl (33 (8, 12, 34) . Human D3, like the Xenopus enzyme and DI, is a selenocysteine-containing protein as evidenced by the presence of an in frame UGA codon, a requirement for an SECIS element for successful translation, and the fact that it incorporates 75Se in a SeID-dependent fashion. The deduced amino acid sequences of the human and Xenopus enzyme are 58% identical (73% similar). In addition, there is 47% similarity with the bifunctional (5' or 5 deiodination) human Dl enzyme which is especially high in the region surrounding the selenocysteine residue ( 11) . to extraction from microsomal membranes by high pH (35) . Hydropathy analysis of the predicted protein revealed a highly hydrophobic amino terminal region of about 40 amino acids which is the only portion of the protein which can qualify as a membrane spanning domain (Fig. 3 B) . The amino-terminal location of this sequence is similar to that found for the DI enzyme (36) . The most significant difference between hD3 and XD3 is the presence of a 12 amino acid insertion at position 51 in the human protein. The location of this insert, just carboxy-terminal to the hydrophobic domain, suggests that it would be found immediately external to the lipid bilayer. If the topology of D3 is similar to that of DI, this would be located in the cytoplasmic compartment (36) . It is a hydrophilic sequence with a number of charged amino acids but its presence does not alter the kinetic characteristics of the human D3 enzyme for either T3 or reverse T3 relative to that of XD3 (17) .
Human D3 mRNA is expressed in placenta and lung. Northern blotting identified a 2.1-2.2-kb transcript in placenta and lung but not in brain. The absence of the expected positive signal in the brain mRNA sample could be explained either by very low mRNA levels in this tissue or by a poor representation of D3 expressing portions of the CNS in the sample examined. In addition, D3 activity is much higher in fetal than in adult rat brain (37) , and we are aware of only one study demonstrating D3 activity in normal adult human brain (38) . D3 activity has been identified in human CNS malignancies (39) , and more extensive studies will be required before this issue can be resolved.
Human D3 can be affinity labeled in vitro by BrAcT3. Previous studies have shown that BrAcT3 is an excellent affinity label for the Dl enzyme (29, 31, 40) . On the other hand, similar techniques were unsuccessful in achieving specific labeling of D3 in rat brain microsomes (35) (Fig. 9) . Recent studies have shown that rat placental D3 activity is not reduced by dietary selenium deficiency as is hepatic DI, leading to the speculation that placental D3 is not a selenoprotein (16) . Since this is unlikely, other explanations for the lack of effect of selenium deficiency on placental D3 activity must be sought. These include either that the placenta, like the brain and thyroid (43, 44) , is resistant to selenium depletion or that selenium incorporation into D3 has a high priority over other pathways of cellular selenocysteine incorporation.
Human D3 contains highly potent SECIS element. Deletion studies confirmed that a SECIS element is located in the 3' ut region of hD3 cDNA. Studies with chimeric Dl/D3 3' ut constructs showed that this sequence is sufficient for the incorporation of Se into a heterologous (Dl) selenoenzyme (Fig.   9 ). We have previously shown that the SECIS element of rat selenoprotein P mRNA consists of two adjacent stem loops and has four times the potency of that in Dl mRNA (32) . The potency of the hD3 SECIS element was comparable to this, suggesting a high priority for selenocysteine incorporation into D3 as well. A portion of this sequence, nt 1478-1720, was less active than the entire 3' ut but still had over twofold the potency of the rat Dl SECIS. This mRNA sequence is predicted to form two stem-loops (Fig. 10 A) though it shares low identity with both the Xenopus 3' ut sequence (39%) and the DI SECIS element (33%). The longer of these (Fig. 10 B) contains two nucleotide sequences conserved in the SECIS elements of D1, GPX, and selenoprotein P (loops 1 and 2) (32). These are YNATGANGR (nt 1611-1619) in the ascending limb of the stem and the unpaired YUGR (nt 1654-1657) on the descending limb (compare Fig. 10, B and C) . However, the predicted loop does not contain the A residues which are also conserved in previously analyzed SECIS structures (32) . Understanding the mechanism by which functional SECIS potency is preserved without this characteristic feature will require further dissection of this structure.
Taken together, these results show that there is a major similarity between the human D3 enzyme and that of Xenopus laevis. In the latter species, the D3 cDNA was identified because the mRNA increased markedly in association with T3-induced tadpole metamorphosis. This suggests it provides a control mechanism to block excessive T3 formation during metamorphosis (17) . Presumably, a similar purpose is served by the presence of D3 in human placenta. Our results show that, despite only 73% similarity and the presence of a 12 amino acid insert in hD3, the catalytic activities of human and Xenopus enzymes are virtually identical. The Km for 5 deiodination of T3 (1 nM) is within the physiological range of circulating T3 concentrations thus indicating the biological relevance of D3 activity. Since we were able to covalently label the transiently expressed protein in a saturable and specific fashion with BrAcT3 we could quantitate the enzyme turnover number. This is two orders of magnitude lower than that for rat Dl which can explain the marked differences in sensitivity of the reaction to PTU inhibition despite the fact that they both contain selenium in the active site (34) . The functional analyses of the 3' ut sequences of D3 mRNA indicate that it is one of the most potent SECIS elements yet identified and that it differs in certain respects from those previously examined. Thus the cloning and functional analysis of human D3 provides the background for both a better comprehension of human maternal-fetal physiology as well as further insights into the biology of mammalian selenoprotein synthesis.
